Systematic review of 73 studies (10,329 patients) of non-systemic therapy for HCC with macrovascular invasion: heterogeneity precluded robust pooling for most treatments; only TARE alone had low heterogeneity, with pooled 1-year overall survival of 34%.
Meta-analysisn = 10,329
Fortuny et al. Hepatocellular carcinoma with macrovascular invasion: Review and survival meta-analysis of initial local therapy using minimal prognostic criteria